Development of a self-tolerant T-cell receptor (TCR) repertoire with the potential to recognize the universe of infectious agents depends on proper regulation of TCR signalling. The repertoire is whittled down during T-cell development in the thymus by the ability of quasi-randomly generated TCRs to interact with selfpeptides presented by major histocompatibility complex (MHC) proteins. Low-affinity TCR interactions with self-MHC proteins generate weak signals that initiate 'positive selection', causing maturation of CD4-or CD8ab-expressing 'single-positive' thymocytes from CD4 1 CD8ab 1 'double-positive' precursors 1 . These develop into mature naive T cells of the secondary lymphoid organs. TCR interaction with high-affinity agonist self-ligands results in 'negative selection' by activation-induced apoptosis or 'agonist selection' of functionally differentiated self-antigen-experienced T cells 2,3 . Here we show that positive selection is enabled by the ability of the T-cell-specific protein Themis 4-9 to specifically attenuate TCR signal strength via SHP1 recruitment and activation in response to low-but not high-affinity TCR engagement. Themis acts as an analog-to-digital converter translating graded TCR affinity into clear-cut selection outcome. By dampening mild TCR signals Themis increases the affinity threshold for activation, enabling positive selection of T cells with a naive phenotype in response to low-affinity self-antigens.
Themis-deficient mice have severely reduced numbers of singlepositive thymocytes and peripheral T cells 4-8 , but the mechanism by which Themis controls T-cell development or function remains obscure. Its rapid phosphorylation after TCR stimulation 4, 9, 10 and subtle signalling defects in Themis 2/2 double-positive thymocytes suggested a role in proximal TCR signalling 4, 9, 11 , although others failed to find any alteration in TCR signalling [5] [6] [7] 10 . Such mild or undetected signalling defects seemed incompatible with the strong positive selection defect in Themis-deficient mice.
We suspected that activation by antibody-mediated TCR crosslinking may have masked genuine signalling defects that would be revealed with more physiological stimulation. Calcium flux is a hallmark of early TCR signalling and is very sensitive to differences in signal strength 12 . We titrated streptavidin crosslinking for anti-CD3/CD4 antibodies to better mimic graded signal strengths TCRs might generate in vivo. Over a broad concentration range, we found only minor reduction in calcium signal in Themis-deficient thymocytes, consistent with our previous observations 4 , but of dubious biological relevance (Extended Data Fig. 1 ). Therefore, we used the well-characterized OT-I TCRtransgenic model 13 to enable thymocyte activation by more physiological MHC proteins ligands. Natural positively selecting and antigen-variant peptides eliciting a full spectrum of signal strengths are well documented (Extended Data Fig. 2a ). OT-I Tap1 2/2 mice express low cell-surface MHC-I, so thymocyte development is arrested at the pre-selection double-positive stage. Therefore OT-I Tap1 2/2 Themis 2/2 or Themis 1/1 thymocytes are an excellent system to study TCR signalling after stimulation with appropriate antigen H-2K b (K b ) tetramers. As expected, Themis-sufficient double-positive thymocytes gave very low but sustained Ca 21 responses to positively selecting peptides Q4H7, Q7 and G4 12 . Remarkably, Themis-deficient cells responded much stronger than Themis-sufficient cells to these ligands, also giving increased responses to lower-affinity E1 and the natural positive-selector Catnb. Responses to strong agonists OVA (the antigenic peptide for OT-I T cells) and its variant A2 (see Extended Data Fig. 2a ) were similar between genotypes ( Fig. 1a -c and Extended Data Fig. 2b ). Similar results were obtained by stimulation on supported lipid bilayers ( Fig. 1d ). These results were confirmed by imaging Ca 21 in thymocytes recognizing RMA-S cells presenting representative high (OVA)-or low (G4)-affinity peptides. Themis-deficient thymocytes responded more strongly than Themis-sufficient to G4, but similarly to OVA (Fig. 1e , f and Extended Data Fig. 3 ). The strong, transient Ca 21 response to negative-selecting ligands versus low, sustained signal to positively selecting ligands 12 , are reflected in differential nuclear translocation of NFATC2 14 . Themis-sufficient thymocytes induced strong, transient NFATC2 translocation in response to K b -OVA tetramer, and delayed but more sustained translocation in response to K b -G4 ( Fig. 1g , Extended Data Fig. 4 ). In contrast, in Themis-deficient thymocytes, both K b -OVA and K b -G4 tetramers induced nearly identical NFATC2 translocation kinetics, similar to the K b -OVA response of wild-type thymocytes. These data demonstrate that the role of Themis in thymocyte signalling is manifest in the response to weak ligands, but masked in responses to strong (agonist) ligands. These differences were largest with ligands below the previously described positive-negative selection border 12 . Differences were noticeable for ligands slightly above this threshold (weak agonists), but were completely masked by antibody crosslinking.
Appropriate ERK signalling kinetics are critical for positive selection [15] [16] [17] . As shown previously, antibody crosslinking induced slightly weaker ERK phosphorylation in Themis-deficient compared to Themissufficient cells 4 (Extended Data Fig. 5 ). Further analysis of phosphorylated (p)-ERK by flow cytometry showed roughly equal p-ERK responses induced with K b -OVA tetramer in both genotypes. However, ERK signalling was faster and stronger in Themis-deficient double-positive cells in response to ligands weaker than K b -OVA ( Fig. 2a, b and Extended Data Fig. 6 ), and confirmed by immunoblot (Extended Data Fig. 5 ). These data further support the notion that Themis 2/2 cells receive signals induced by classical positive-selecting ligands as activating signals, similar to negative/agonist ligand-induced signals.
The subcellular localization of p-ERK in thymocytes differs with ligand affinity, with negative/agonist-selection stimuli inducing p-ERK more proximal to the plasma membrane than positive-selection stimuli, which induced p-ERK deeper within the cell 12 . To determine whether Themis controls the topology of TCR-induced ERK activation, we compared p-ERK localization in Themis-deficient or Themis-sufficient pre-selection double-positive thymocytes responding to different ligands ( Fig. 2c, d and Extended Data Fig. 7 ). Weak ligands that normally induce intracellular p-ERK in Themis-expressing cells instead gave a relatively high proportion of membrane-proximal p-ERK in Themis 2/2 DPs. In aggregate, these data indicate that, without Themis, the ERK cascade 
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was both mis-localized and hyperactivated, so that positive-selecting ligands were mistakenly interpreted as negative/agonist-selectors. Thus, Themis 2/2 double-positive cells seem unable to precisely distinguish low-affinity from high-affinity TCR signalling. Both the Ca 21 response and ERK signalling cascade occur distal to TCR stimulation. We therefore examined more proximal signalling events to determine where these marked changes in signal transduction to low-affinity ligands were initiated. We found substantially elevated phosphorylation of LAT and PLCc1 (Fig. 3a) , although not SLP-76 (Extended Data Fig. 8 ), in Themis-deficient versus Themissufficient cells upon stimulation with low-affinity ligands. This point of action is consistent with previous reports that Themis interacts with PLCc1 and is part of the LAT signalosome 4, 9, 11 . These data demonstrate that Themis 2/2 cells mount an augmented response to low-affinity ligands, similar to a wild-type response to high-affinity ligands, indicating that Themis restricts TCR signalling in double-positive cells stimulated by low-affinity ligands. SHP1, a cytoplasmic protein tyrosine phosphatase, is an important negative regulator in TCR signalling (reviewed in ref. 18) . It is activated by tyrosine phosphorylation, and reported to control the thresholds for positive and negative selection [18] [19] [20] [21] . To test if Themis might limit TCR signalling by controlling SHP1, we analysed SHP1 phosphorylation in Themis 1/1 and Themis 2/2 doublepositive cells. Notably, p-SHP1 (but not total protein) was markedly decreased in Themis-deficient cells, clearly opposite to enhanced p-ERK. Indeed p-SHP1 was barely induced in the Themis-deficient cells ( Fig. 3b and Extended Data Fig. 9 ). Moreover, Themis interacted constitutively with SHP1 but p-SHP1 was induced in Themis-SHP1 complexes in response to TCR stimulation ( Fig. 3c ). Themis-GRB2 binding was constitutive ( Fig. 3d ) [5] [6] [7] 9 . Because activated LCK is a SHP1 substrate 18, 22 , we tested LCK phosphorylation, finding that the activated pY394 form was indeed increased in Themis-deficient thymocytes ( Fig. 3e) .
These results suggest that Themis 'caps' the signal strength by controlling SHP1 activation, moderating strength and kinetics of responses to relatively low-affinity ligands. This allows these self-antigen-experienced cells to mature into naive T cells. Without Themis, thymocytes receive strong agonist/negative-selection-like signals. To test whether these redirect low-affinity stimulation to induce negative selection, we stimulated pre-selection double-positive thymocytes with K b -tetramers, and assayed caspase-3 activation, a readout for apoptosis 23 . Indeed, caspase-3 activation was significantly increased in Themis 2/2 versus Themis 1/1 cells in response to ligands that normally induce positive selection, but was similar for ligands that normally induce negative selection (Fig. 4a, left) . Reduced activated caspase-3 1 cells in OVAstimulated populations versus weaker ligands is probably due to phagocytosis of dead cells, as OVA signals were clearly stronger based on TCR downmodulation (Fig. 4a, right) . Deficiency of the pro-apoptotic protein Bim rescues thymocytes from negative selection 24 . Intriguingly, Bim co-disruption rescued the previously reported 4-8 impaired singlepositive thymocyte development in Themis 2/2 mice and defective CD8SP thymocyte development in OT-I Themis 2/2 mice (Fig. 4b, c ). This indicated that the defect in thymocyte development in Themis 2/2 To test this, we simultaneously examined development of wild-type and Themis-deficient T cells in mixed bone marrow chimaeras, avoiding potential homeostatic proliferation artefacts (Fig. 4d ). Themis 1/1 vastly outnumbered Themis 2/2 cells among conventionally selected naive peripheral T cells, but TCRcd 1 intra-epithelial lymphocytes (IEL), TCRab 1 CD8aa IELs and liver iNKT-cells, which all are selected from double-positive cells by strong TCR signals 2,3,25 , showed roughly equal reconstitution by both genotypes. Thus, development of agonistselected T cells is not, or at most very mildly, affected by the absence of Themis, in contrast to generation of peripheral naive T cells, supporting our notion that the role of Themis differs in relation to ligand strength. This study shows that Themis acts early in the TCR signalling cascade, reducing signal strength in response to low-affinity but not high-affinity MHC proteins ligands. Without Themis, TCR signalling in response to low-affinity MHC proteins ligands mimics normal signalling responses to negative or agonist-selecting ligands, generating stronger signals that redirect the selection outcome. Themis performs this function through controlling recruitment and activation of the phosphatase SHP1, which limits TCR signalling and reportedly affects the thresholds for positive and negative selection [19] [20] [21] , as well as helping discriminate between agonist and lower-affinity antagonist ligands 22 . A recent study using a conditional knockout of SHP1, where deletion occurred at the immature double-positive stage of thymocyte development, showed that SHP1 was not required for normal thymocyte development 26 . It is possible that incomplete deletion of SHP1 mediated by transgenic CD4-Cre may mask the requirement of SHP1 in thymocyte development. Alternatively other phosphatases can act redundantly in selection 26 . The dominant negative SHP1 transgenes that appeared to show the involvement of SHP1 in development 19, 20 would likely have blocked other phosphatases in addition to SHP1. We therefore tested whether Themis is able to interact with SHP2. We found that Themis indeed interacts constitutively with SHP2 (Extended Data Fig. 10 ), indicating that the lack of a Themis 2/2 -like phenotype in the conditional SHP1 knockout is probably owing to redundancy between phosphatases, raising the possibility that different phosphatases may be important in TCR signalling in different situations.
Themis acts to enforce the threshold between positive and negative/ agonist selection, which occurs over a very narrow range of TCR-MHC protein affinities 12 . Themis causes an analog continuum of TCR affinities to elicit a digital selection outcome-positive versus negative/ agonist selection. We speculate that altered Themis expression shifts the selection window, changing the mature TCR repertoire, and therefore affecting disease susceptibility. Indeed, single-nucleotide polymorphisms in the noncoding region between human THEMIS and PTPRK genes have been associated with susceptibility to coeliac disease and multiple sclerosis [27] [28] [29] . More work is needed to understand the connection between these polymorphisms, Themis expression and the aetiology of disease.
METHODS SUMMARY
Animal experiments were performed in accordance with the TSRI Animal Care and Use Committee. Thymocytes from Themis 1/1 or Themis 2/2 OT-I Tap1 2/2 4-6-week-old mice, both sexes, were used. For ex vivo experiments, thymocytes were rested 3 h at 37 uC before assay. For Ca 21 assays, knockout cells were prelabelled with Cy5 and mixed with wild-type cells (or vice versa), loaded with Ca 21sensitive dye (indo-1-AM for flow cytometry or Fluo-4 for imaging), then washed in Ca 21 /Mg 21 -free medium, 1 mM EGTA 30 . Cells were stimulated with tetramers for flow cytometry 30 , or with antigen-presenting lipid bilayers or peptide-loaded RMA-S cells for imaging. After allowing cells to settle, 1 v/v pre-warmed medium containing 2.5 mM CaCl 2 and MgCl 2 was added (t 5 0). For biochemistry, thymocytes were stimulated with tetramers or antibodies, and analysed by western blot as described 4,12 . Rabbit anti-Themis antibody (Millipore 06-1328) was used in immunoprecipitation and blotting.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Mice. Themis 2/2 mice (B6.129S-Themis tm1Gasc ) were produced at TSRI and are available from Jackson Laboratory (Stock 010919). C57BL/6 (Thy1.2 1 CD45.2 1 ) mice were bred at TSRI. OT-I and OT-I Tap1 2/2 animals were obtained from S. Jameson and K. Hogquist and Bim knockout mice from L. Sherman. All experiments were performed in accordance with the guidelines of the Animal Care and Use Committee of TSRI. Antibodies. Anti-CD3 (145-2C11), anti-CD4 (RM4.4, RM4.5 and GK1.5), anti-CD8a (53-6.7), anti-CD8b (G35217.2)) and anti-Va2 (B20.1) were from eBioscience or Biolegend. Antibodies against phosphorylated extracellular signal-regulated kinase 1 and 2 (ERK1/2) (T 202 /Y 204 , catalogue no. 9101), phosphorylated PLC-c1 (catalogue no. 2821), phosphorylated LAT (catalogue no. 3584), phosphorylated SHP1 (catalogue no. 8849), VAV (catalogue no. 2502), and NFATC2 (also known as NFAT1) (catalogue no. 5861) were from Cell Signaling Technology. Anti-phosphorylated tyrosine (4G10, catalogue no. 05-1050) and rabbit anti-Themis antibody were from Millipore (catalogue no. 06-1328). Anti-SHP1 antibody was from Santa Cruz Biotechnology (sc-287). Phospho-Src family (Tyr416) antibody (Cell Signaling catalogue no. 2101) cross-reacts with other Src-family kinases phosphorylated at the activating site. As a result probing thymocyte lysates with this monoclonal antibody shows phosphorylated forms of both p56 Lck and p59 Fyn. Ca 21 flux. Ca 21 flux measurement by flow cytometry was performed as previously described 30 . Thymocytes from Themis 1/1 or Themis 2/2 OT-I Tap1 2/2 4-6-week-old mice, both sexes, were used. Briefly, thymocyte suspensions were prepared, put in separate tubes and rested 3 h at 37 uC before assay. One of the two cell types was loaded for 5 min at room temperature with indodicarbocyanine (Cy5; 1 mg ml 21 ) or was mock treated, followed by washing. Equal numbers of Cy5-labelled cell populations were mixed with the unlabelled sample; for example, OT-I Tap1 2/2 Themis 1/1 (mock) plus OT-I Tap1 2/2 Themis 2/2 (Cy5). Cells were suspended at a density of 2 3 10 6 -6 3 10 6 cells per ml in cRPMI (RPMI medium supplemented with 10% (v/v) FCS, 100 U ml 21 of penicillin, 10 mg ml 21 of streptomycin, 292 mg ml 21 of glutamine, 50 mM 2-mercaptoethanol and 25 mM HEPES, pH 7.3) and were incubated for 30 min at 37 uC in 5% CO 2 with the calcium indicator Indo-1-AM (2 mM; Molecular Probes). Cells were washed twice with cRPMI. For antibody stimulation, cells were stained for 20 min on ice with biotinconjugated anti-CD3 and anti-CD4 (RM4.4), as well as PerCP-Cy5.5-conjugated anti-CD8a and phycoerythrin (PE)-conjugated anti-CD4 (GK1.5) in cRPMI. Cells were washed once with cRPMI and once with cHBSS (Ca 21 -free and Mg 21 -free Hank's balanced-salt solution supplemented with 1% (v/v) FCS, 1 mM MgCl 2 , 1 mM EGTA and 10 mM HEPES, pH 7.3) and were resuspended in cHBSS. Cells were prewarmed to 37 uC before analysis and were kept at 37 uC during event collection on an LSR II (Becton Dickinson). For cell stimulation, streptavidin (10 mg ml 21 ; Jackson ImmunoResearch) was added to crosslink biotinylated antibodies; alternatively, cells were stimulated with tetramers (NIH tetramer core facility). CaCl 2 (2 mM) was added during analysis. Mean fluorescence ratio was calculated with FlowJo (TreeStar). Imaging of Ca 21 flux. Knockout cells were prepared and pre-labelled with Cy5 as above 30 then both wild-type and knockout cells were mixed and loaded with 2 mM Ca 21 -sensitive dye Fluo-4. After washing in Ca 21 /Mg 21 -free medium with 1 mM EGTA, cells were mixed and added to the 37 uC imaging chamber containing either the antigen-presenting lipid bilayer or peptide-loaded RMA-S cells. After allowing cells to settle and starting imaging, 1 volume of pre-warmed medium containing 2.5 mM CaCl 2 and 2.5 mM MgCl 2 was added so that Ca 21 influx started at t 5 0. p-ERK analysis. For intracellular staining of phosphorylated ERK, stimulated cells were fixed with 4% paraformaldehyde for 12 min at room temperature and then plated in microtitre tubes (for phospho-flow analysis) or in poly-L-lysinecoated LabTek II chambers (for imaging). Cells were permeabilized with 0.3% Triton X-100 for 3 min at room temperature. Cells were then blocked with 5% normal goat serum and incubated with rabbit monoclonal antibody against phospho-ERK, after which they were incubated with Alexa Fluor 488-conjugated Fab fragments against rabbit antibodies (Molecular Probes) for secondary detection (either phospho-flow or microscopy). For flow cytometry analysis, one of the two cell types were pre-labelled with dye Cy5 and the other one was mock labelled. Then the two cell types were mixed in 1:1 ratio and processed for stimulation and staining. Phospho-flow analysis of p-ERK was done on a BD LSR-II digital flow cytometer and the two cell types were distinguished by Cy5 labelling. p-ERK imaging was done as described previously with modification 31 . Briefly, after intracellular staining of p-ERK, nuclei were counterstained with the DNA binding dye 49,6-diamidino-2-phenylindole (DAPI, Invitrogen). All images were captured with a Zeiss Axiovert 200 M inverted microscope. SlideBook software (Intelligent Imaging Innovations) was used for the capture as well as for deconvolution and image analysis, and ImageJ was used for image presentation.
NFATC2 imaging. Nuclear translocation of NFATC2 (NFAT1) was imaged as described above regarding p-ERK imaging 31 , and analysed using CellProfiler software (Broad Institute). Immunoprecipitation and western blotting analysis. Briefly, cells were stained with antibodies against CD3 and CD4 or tetramers on ice for 15 min and stimulated by rapidly warming to 37 uC with pre-warmed PBS for indicated times. Cells were then lysed and processed for immunoprecipitation or immunoblot analysis as described in detail in ref. 32 . In some cases, after primary antibody incubation, membranes were incubated with goat anti-rabbit IgG (H1L), DyLight 800-conjugated (Pierce, catalogue no. 35571) or goat anti-mouse IgG (H1L), DyLight 680conjugated (Pierce, catalogue no. 35519), and detected and quantified with a LiCor Odyssey infrared imaging system. Human embryonic kidney epithelial cells (HEK293), which express SHP2 but little SHP1 33, 34 , were transfected by calcium phosphate precipitation and lysates prepared as described 11 . Streptactin-Sepharose beads (IBA BioTAGnology) were used for THEMIS-Strep pull-downs, after which beads were washed three times with lysis buffer. Bound proteins were eluted with 5 mM biotin and subjected to SDS-PAGE 11 .
In vitro apoptosis assay. Experiments were performed as described previously 23 . Briefly, pre-selection thymocytes were stimulated with the various tetramers for 17 h. Apoptosis was determined by staining active caspase-3 with fluorescein isothiocyanate (FITC)-conjugated specific antibody following the manufacturer's protocol (APO ACTIVE 3 detection kit, Cell Technology, catalogue no. FAB200-1), and analysed by FACS.
Phenotyping of agonist-selected T cells. Agonist-selected T cells were analysed in bone marrow reconstituted mice. Briefly, Themis 1/1 (CD45.1 1 /CD45.2 1 ) and Themis 2/2 bone marrow cells (CD45.2 1 ) were mixed 1:1 and injected into lethally irradiated (2 3 5.5 Gy, separated by 3-4 h) B6 recipient mice (CD45.1 1 ). At various times post bone marrow reconstitution, tissues and organs of recipient mice were collected and relevant T-cell subsets were analysed. Splenocytes, IELs and liver mononuclear cells were prepared as previously described 35, 36 . Cells were suspended in PBS 1 5% FCS 1 0.16% azide and anti-CD16/CD32 (2.4G2) Fc-receptor antibody (BD Biosciences) was used to block Fc-antibody binding. The following antibodies were purchased from BD Biosciences: TCRcd-FITC (GL3), TCRb-APC-ef780 (H57-597), NK1.1-FITC (PK136), CD8a-PE (53-6.7), CD8b-FITC (53-5.8), CD19-APC (1D3), CD45.2-PercP-Cy5.5 (104). The following antibodies were purchased from eBioscience: CD4-eF450 (RM4-5), CD5-ef450 (53-7.3), CD45.1-PE-Cy7 (A20), CD69-eF450 (H1.2F3), CD90.2-APC (53-2.1). The following antibodies were purchased from Invitrogen: CD8a-PO (5H10). The following antibodies were purchased from Caltag: CD4-PO (RM4-5). All antibodies were directly conjugated to fluorophores. An LSR II cell analyser (BD Biosciences) was used for the flow cytometry, and FlowJo software (TreeStar) was used for analysis. Statistical testing. Statistics were performed as described in Figure legends using Excel, GraphPad Prism, or Igor Pro (Wavemetrics).
